Patent details

EP2576492 Title: TREPROSTINIL PRODUCTION

Basic Information

Publication number:
EP2576492
PCT Application Number:
US2011038946
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117904177
PCT Publication Number:
WO2011153363
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREPROSTINIL PRODUCTION
French Title of Invention:
PRODUCTION DE TRÉPROSTINIL
German Title of Invention:
TREPROSTINILHERSTELLUNG
SPC Number:

Dates

Filing date:
02/06/2011
Grant date:
20/09/2017
EP Publication Date:
10/04/2013
PCT Publication Date:
08/12/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/09/2017
EP B1 Publication Date:
20/09/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/06/2018
Expiration date:
02/06/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/09/2017
 
 

Name:
United Therapeutics Corporation
Address:
1040 Spring Street, Silver Spring, MD 20910, United States (US)

Inventor

1

Name:
WALSH, David A.
Address:
United States (US)

2

Name:
TULADHAR, Sudersan M.
Address:
United States (US)

3

Name:
PENMASTA, Raju
Address:
United States (US)

4

Name:
SHARMA, Vijay
Address:
United States (US)

5

Name:
BATRA, Hitesh
Address:
United States (US)

Priority

Priority Number:
351115 P
Priority Date:
03/06/2010
Priority Country:
United States (US)

Classification

IPC classification:
C07C 51/09; C07C 51/367; C07C 59/72; C07C 67/343; C07C 69/736; C07C 253/30;

Publication

European Patent Bulletin

Issue number:
201738
Publication date:
20/09/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1